Cancer Drugs Ushered Through FDA's Accelerated Approval Show No Clinical Benefit [Study] Medicine & Technology Apr 15, 2024 About 40% of those fast-tracked anti-cancer drugs show no clinical benefits, according to a new study. Continue reading to learn more.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts